EREG and rectal cancer: In contrast, the epiregulin (EREG) gene was one of the top 200 genes that were co-downregulated with MUC2 (Spearman’s correlation: −0.379) (Supplementary Figure S1B) and one of the favorable factors among rectal cancer patients receiving CCRT in our previous research [27].